Tata Chemicals

Tata Chemicals reported a weak Q4 FY26 with consolidated revenue down 2% YoY to ₹3,438 croreCurrent reported value: 2% YoY to ₹3,438 crore. No comparable prior figure is available in the source record. and EBITDA falling 16% to ₹274 croreCurrent reported value: 16% to ₹274 crore. No comparable prior figure is available in the source record., reflecting subdued soda ash prices globally and higher costs. The US business took a ₹1,837 crore goodwill impairmentCurrent reported value: ₹1,837 crore goodwill impairment. No comparable prior figure is available in the source record. due to prolonged pricing pressure. Standalone revenue grew 3% to ₹1,254 croreCurrent reported value: 3% to ₹1,254 crore. No comparable prior figure is available in the source record. on higher volumes, but EBITDA margin contracted. Management highlighted that Middle East conflict has driven up energy and shipping costs, though most cost increases have been passed on. Imports into India have halved, supporting domestic volumes. Capex for FY27 is guided at ₹1,300 croreCurrent reported value: ₹1,300 crore. No comparable prior figure is available in the source record., mainly maintenance, with debt expected to stay near ₹6,000 crore. The company is pivoting to non-soda ash businesses (up 14% YoY to ₹6,946 crCurrent ₹6,946 Cr. Reported change: +14% YoY.ore). Key risk: prolonged conflict could erode demand and further pressure margins.